Silicon Valley Capital Partners Astrazeneca PLC Transaction History
Silicon Valley Capital Partners
- $767 Million
- Q3 2024
A detailed history of Silicon Valley Capital Partners transactions in Astrazeneca PLC stock. As of the latest transaction made, Silicon Valley Capital Partners holds 552 shares of AZN stock, worth $39,423. This represents 0.01% of its overall portfolio holdings.
Number of Shares
552
Previous 549
0.55%
Holding current value
$39,423
Previous $42,000
2.38%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,345Shares Held
492MCall Options Held
4.99MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.64 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.04 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.9 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.62 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.26 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $221B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...